Dr. Wrabetz findings on protein synthesis and myelin restoration published in the Journal of Experimental Medicine

See the full article from UB News featuring the publication and download the
published research 

Jill Kelly accepts the
Samuel P. Capen award
from UB on behalf of
Hunter James Kelly & Leukodystrophy Families

See excerpt from the program and learn
about the Samuel P. Capen Award

 
The Boy in the Neighborhood

"He may not be able
to speak audibly,
but let him speak volumes
of inspiration. 

When you are discouraged,
may the 'Boy' encourage you.

May we all work together to find those solutions for Krabbe and the other diseases that steal the joy we were created to have."

~ by Anne McCune 

Read the full presentation of
Boy with the Heart of Hope
finding his place in
the neighborhood...

 Additional News & Media

Hunter James Kelly Research Institute

From the inception of Hunter's Hope in 1997, an overarching goal of the Foundation has been to fund research into the cause, prevention, treatment and clinical care for children suffering from Krabbe and other leukodystrophies. 

To that end, Hunter's Hope entered into an agreement in 2008 with the University at Buffalo School of Medicine, to create the Hunter James Kelly Research Institute.

All Foundation funded research, including both clinical and basic science, is coordinated through the Institute, which is located in the New York State Center of Excellence in Bioinformatics and Life Sciences (CoE), a prominent part of the Buffalo Niagara Medical Campus.

The mission of the HJKRI is to study myelin and its diseases.  Myelin is the fatty insulation around axons (the wires of the nervous system) in the brain, spinal cord and nerves. The HJKRI incorporates both basic and clinical science programs.

Basic research is based on a multi-disciplinary approach to understand how myelin is formed, how it is damaged in disease, and how it may be repaired.  In particular, HJKRI will study disease mechanisms of Krabbe Disease in order to formulate therapies.

Clinical research analyzes information revealed by newborn screening for Krabbe Disease and other leukodystrophies. The World Wide Registry for patients with Krabbe Disease aims to improve diagnosis and prognosis, and to provide outcome measures for clinical trials.

This integrated approach, together with a critical mass of resources and investigators, will generate information that will promote effective treatment strategies not only for children with leukodystrophies, but also patients with Multiple Sclerosis, stroke, neuropathies and other diseases in which myelin is damaged.

The Inagural White Coat Tour

March 8, 2012
Hunter James Kelly Research Institute

The evening included an
exclusive four part tour
of the Center of Excellence
in Bioinformatics and Life Sciences,
where the HJKRI occupies the 4th floor. 

Click the photo for an album of evening highlights